There are currently, however, two radioligands that are United States Food and Drug Administration (FDA)-approved for the treatment of mCRPC patients: Patients with advanced prostate cancer are at ...

Lung metastasis (from metastatic breast cancer) resolved - after only 2 months (4 doses) of treatment with Bria-OTS™ ...

Therapeutics announces an unprecedented clinical response including resolution of a lung metastasis with stable disease ...

Follicular thyroid cancer with bone involvement was associated with a significantly elevated risk for brain metastases among women.

Lung metastasis (from metastatic breast cancer) resolved - after only 2 months (4 doses) of treatment with Bria-OTS ...

A recent study has uncovered the molecular mechanisms behind osteocyte death in melanoma bone metastasis, revealing that ferroptosis—an iron-dependent form of cell death—plays a central role in the ...

During a Case-Based Roundtable event, Laura Huppert, MD, discussed data and considerations around using T-DXd in breast ...

The management of bone metastases in endocrine-related cancers is a continually evolving field, marked by significant challenges and advances that affect ...

On World Cancer Day, we got in touch with an Orthopaedic Oncologist who shares the importance of early detection and expert ...

Medically reviewed by Aleesha Grier, PsyD Metastatic breast cancer affects people in many ways. The symptoms experienced by ...

The European Medicines Agency has recommended three new medicines to treat breast and cervical cancer and ...